World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
14022
World Ranking
4117
National Ranking
1877

Overview

Andrea L. Cox is affiliated with the Johns Hopkins University School of Medicine in the United States. Their research primarily focuses on the field of Medicine with a significant contribution to Infectious Diseases, Epidemiology, Hepatology, Immunology, and Neurology.

The scientist's recent publication record includes several articles addressing various infectious disease topics. Notable recent papers include:

  • Progress towards elimination goals for viral hepatitis (2020), published in Nature Reviews Gastroenterology & Hepatology
  • Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection (2021), published in New England Journal of Medicine
  • The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV) (2021), published in Clinical Infectious Diseases
  • Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury (2021), published in JCI Insight
  • Metabolic programs define dysfunctional immune responses in severe COVID-19 patients (2021), published in Cell Reports

The scientist collaborates frequently with other researchers, with recurrent co-authors including Andrew H. Karaba, Andrew Pekosz, Sabra L. Klein, Aaron A.R. Tobian, and Joel N. Blankson.

Their publications appear most often in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • The Journal of Immunology
  • JCI Insight

Main areas of research topics addressed by Andrea L. Cox include:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 detection and testing
  • Liver Disease Diagnosis and Treatment

Best Publications

  • Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

    Donald F. Hunt;Robert A. Henderson;Jeffrey Shabanowitz;Kazuyasu Sakaguchi

  • Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines

    Andrea L. Cox;Jonathan Skipper;Ye Chen;Robert A. Henderson

  • Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad

    Donald F. Hunt;Hanspeter Michel;Tracey A. Dickinson;Jeffrey Shabanowitz

  • Protection against persistence of hepatitis C.

    Shruti H. Mehta;Andrea Cox;Donald R. Hoover;Xiao Hong Wang

  • The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

    Jason Grebely;Kimberly A Page;Rachel Sacks-Davis;Martin Schim van der Loeff

  • Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity against Persistent Reinfection

    William O. Osburn;Brian E. Fisher;Kimberly A. Dowd;Giselle Urban

  • Cellular immune selection with hepatitis C virus persistence in humans

    Andrea L. Cox;Timothy Mosbruger;Qing Mao;Zhi Liu

  • Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C

    Ashwin Balagopal;Frances H. Philp;Jacquie Astemborski;Timothy M. Block

  • A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction.

    Dung T. Le;Dirk G. Brockstedt;Ran Nir-Paz;Johannes Hampl

  • Prospective Evaluation of Community‐Acquired Acute‐Phase Hepatitis C Virus Infection

    Andrea L. Cox;Dale M. Netski;Timothy Mosbruger;Susan G. Sherman

  • Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

    Andrea L. Cox;Timothy Mosbruger;Georg M. Lauer;Drew Pardoll

  • Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses.

    William O. Osburn;Anna E. Snider;Brittany L. Wells;Rachel Latanich

  • Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.

    Kimberly A. Dowd;Dale M. Netski;Xiao–Hong Wang;Andrea L. Cox

  • Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

    Jason Grebely;Maria Prins;Margaret Hellard;Andrea L Cox

  • TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer.

    Benjamin V. Park;Zachary T. Freeman;Ali Ghasemzadeh;Michael A. Chattergoon

  • Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

    Priya Duggal;Chloe L. Thio;Genevieve L. Wojcik;James J. Goedert

  • Humoral Immune Response in Acute Hepatitis C Virus Infection

    Dale M. Netski;Tim Mosbruger;Erik Depla;Geert Maertens

  • Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.

    Justin R. Bailey;Eleanor Barnes;Andrea L. Cox

  • HIV and HCV Activate the Inflammasome in Monocytes and Macrophages via Endosomal Toll-Like Receptors without Induction of Type 1 Interferon

    Michael A. Chattergoon;Rachel Latanich;Jeffrey Quinn;Matthew E. Winter

  • Progress towards elimination goals for viral hepatitis

    Andrea L. Cox;Manal Hamdy El-Sayed;Jia-Horng Kao;Jeffrey V. Lazarus

  • Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes

    C L Slingluff;A L Cox;R A Henderson;D F Hunt

Frequent Co-Authors

David L. Thomas
David L. Thomas Johns Hopkins University
Arthur Y. Kim
Arthur Y. Kim Harvard University
Stuart C. Ray
Stuart C. Ray Johns Hopkins University School of Medicine
Georg M. Lauer
Georg M. Lauer Harvard University
Andrew R. Lloyd
Andrew R. Lloyd University of New South Wales
Margaret Hellard
Margaret Hellard Burnet Institute
Jason Grebely
Jason Grebely University of New South Wales
Gregory J. Dore
Gregory J. Dore University of New South Wales
Maria Prins
Maria Prins University of Amsterdam
Lisa Maher
Lisa Maher University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open diverse career opportunities. Nursing is a common pathway, with many professionals advancing through flexible online programs. For example, students can accelerate their careers with accelerated nurse practitioner programs, which build on prior experience or education for quicker entry into advanced practice roles.

Individuals without a nursing background looking to enter the field might consider online ABSN programs for non nurses. These programs provide a comprehensive nursing education online, enabling a faster transition into clinical roles.

If you are seeking less competitive ways to enter nursing, exploring the easiest accelerated nursing programs to get into can help you find viable pathways that match your timeline and academic strengths.

For those interested in entry-level nursing careers, easiest LPN programs to get into offer practical routes into patient care, often with shorter training periods. These pathways complement Immunology expertise in clinical settings and enhance career versatility.

Best Scientists Citing Andrea L. Cox

Trending Scientists

Recently Published Articles